This compound is primarily utilized in the synthesis of pharmaceutical agents, particularly those targeting neurological and cardiovascular conditions. Its structure, featuring both amino and dihydroxyphenyl groups, makes it a valuable intermediate in the production of dopamine-related drugs, which are essential for treating Parkinson's disease and other dopamine-deficiency disorders. Additionally, it serves as a precursor in the development of antioxidants and anti-inflammatory medications, leveraging its phenolic properties to combat oxidative stress and inflammation in various therapeutic contexts. Its ester functionality also allows for further chemical modifications, enhancing its versatility in drug design and development.